Cargando…

Serum B-cell activating factor and lung ultrasound B-lines in connective tissue disease related interstitial lung disease

OBJECTIVE: To investigate the role of serum B-cell activating factor (BAFF) and lung ultrasound (LUS) B-lines in connective tissue disease related interstitial lung disease (CTD-ILD), and their association with different ILD patterns on high resolution computed tomography (HRCT) of chest. METHODS: W...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yukai, Xie, Xuezhen, Zheng, Shaoyu, Du, Guangzhou, Chen, Shaoqi, Zhang, Weijin, Zhuang, Jinghua, Lin, Jianqun, Hu, Shijian, Zheng, Kedi, Mikish, Angelina, Xu, Zhuangyong, Zhang, Guohong, Gargani, Luna, Bruni, Cosimo, Hoffmann-Vold, Anna-Maria, Matucci-Cerinic, Marco, Furst, Daniel E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798453/ https://www.ncbi.nlm.nih.gov/pubmed/36590969 http://dx.doi.org/10.3389/fmed.2022.1066111

Ejemplares similares

The role of lung ultrasound B-lines and serum KL-6 in the screening and follow-up of rheumatoid arthritis patients for an identification of interstitial lung disease: review of the literature, proposal for a preliminary algorithm, and clinical application to cases
por: Wang, Yukai, et al.
Publicado: (2021)

Lung ultrasound B-lines and serum KL-6 correlate with the severity of idiopathic inflammatory myositis-associated interstitial lung disease
por: Wang, Yukai, et al.
Publicado: (2020)

Usefulness of lung ultrasound B-lines in connective tissue disease-associated interstitial lung disease: a literature review
por: Wang, YuKai, et al.
Publicado: (2017)

Lung Ultrasound B-Lines in the Evaluation of the Extent of Interstitial Lung Disease in Systemic Sclerosis
por: Bruni, Cosimo, et al.
Publicado: (2022)

Rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren’s syndrome shared megakaryocyte expansion in peripheral blood
por: Wang, Yukai, et al.
Publicado: (2022)

The Treatment of Lung Involvement in Systemic Sclerosis
por: Ruaro, Barbara, et al.
Publicado: (2021)

Impact of lung function and baseline clinical characteristics on patient-reported outcome measures in systemic sclerosis-associated interstitial lung disease
por: Kreuter, Michael, et al.
Publicado: (2022)

The contribution of epigenetics to the pathogenesis and gender dimorphism of systemic sclerosis: a comprehensive overview
por: Fioretto, Bianca Saveria, et al.
Publicado: (2020)

Computed Tomography Predictors of Mortality or Disease Progression in Systemic Sclerosis–Interstitial Lung Disease: A Systematic Review
por: Landini, Nicholas, et al.
Publicado: (2022)

Open questions on the management of targeted therapies for the treatment of systemic sclerosis-interstitial lung disease: results of a EUSTAR survey based on a systemic literature review
por: Campochiaro, Corrado, et al.
Publicado: (2022)

Combination of Salivary Gland Ultrasonography and Virtual Touch Quantification for Diagnosis of Sjögren's Syndrome: A Preliminary Study
por: Chen, Shaoqi, et al.
Publicado: (2016)

The Role of Bronchoalveolar Lavage in Systemic Sclerosis Interstitial Lung Disease: A Systematic Literature Review
por: Orlandi, Martina, et al.
Publicado: (2022)

Systemic sclerosis in the time of COVID-19
por: Hoffmann-Vold, Anna-Maria, et al.
Publicado: (2022)

The systemic sclerosis patient in the COVID-19 era: the challenging crossroad between immunosuppression, differential diagnosis and long-term psychological distress
por: Orlandi, Martina, et al.
Publicado: (2020)

Combined lung and cardiac ultrasound in COVID-related acute respiratory distress syndrome
por: Lazzeri, Chiara, et al.
Publicado: (2021)

Clinical trials in systemic sclerosis: lessons learned and outcomes
por: Matucci-Cerinic, Marco, et al.
Publicado: (2007)

Bronchoalveolar lavage and lung biopsy in connective tissue diseases, to do or not to do?
por: Tomassetti, Sara, et al.
Publicado: (2021)

Interstitial lung disease in systemic sclerosis: where do we stand?
por: Cappelli, Susanna, et al.
Publicado: (2015)

Lung ultrasound: a new tool for the cardiologist
por: Gargani, Luna
Publicado: (2011)

Decreased Serum Levels of SIRT1 and SIRT3 Correlate with Severity of Skin and Lung Fibrosis and Peripheral Microvasculopathy in Systemic Sclerosis
por: Manetti, Mirko, et al.
Publicado: (2022)

How I do it: Lung ultrasound
por: Gargani, Luna, et al.
Publicado: (2014)

Role of miR-449b-3p in endometriosis via effects on endometrial stromal cell proliferation and angiogenesis
por: Liu, Yukai, et al.
Publicado: (2018)

Vascular Leaking, a Pivotal and Early Pathogenetic Event in Systemic Sclerosis: Should the Door Be Closed?
por: Bruni, Cosimo, et al.
Publicado: (2018)

COVID-19 and systemic sclerosis: Rising to the challenge of a pandemic
por: Denton, Christopher P, et al.
Publicado: (2020)

What are the minimum requirements to establish proficiency in lung ultrasound training for quantifying B‐lines?
por: Russell, Frances M., et al.
Publicado: (2020)

The MUC5B Variant Is Associated with Idiopathic Pulmonary Fibrosis but Not with Systemic Sclerosis Interstitial Lung Disease in the European Caucasian Population
por: Borie, Raphael, et al.
Publicado: (2013)

Heterogeneity of determining disease severity, clinical course and outcomes in systemic sclerosis-associated interstitial lung disease: a systematic literature review
por: Petelytska, Liubov, et al.
Publicado: (2023)

Registry Evaluation of Digital Ulcers in Systemic Sclerosis
por: Galluccio, Felice, et al.
Publicado: (2010)

Immune dysfunction in COVID-19 and judicious use of antirheumatic drugs for the treatment of hyperinflammation
por: TUFAN, Abdurrahman, et al.
Publicado: (2021)

The Contribution of Imaging Beyond Clinical Diagnosis, the Ochronosis and Synovio-entheseal Complex Examples
por: Pacini, Giovanni, et al.
Publicado: (2022)

Patient-level factors predictive of interstitial lung disease in rheumatoid arthritis: a systematic review
por: Matteson, Eric L., et al.
Publicado: (2023)

Interleukin-1 and Systemic Sclerosis: Getting to the Heart of Cardiac Involvement
por: De Luca, Giacomo, et al.
Publicado: (2021)

Diagnostic and Prognostic Value of Lung Ultrasound B-Lines in Acute Heart Failure With Concomitant Pneumonia
por: Mazzola, Matteo, et al.
Publicado: (2021)

A simple, reproducible and accurate lung ultrasound technique for COVID-19: when less is more
por: Volpicelli, Giovanni, et al.
Publicado: (2021)

Potential Role of JAK Inhibitors in the Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease: A Narrative Review from Pathogenesis to Real-Life Data
por: Fiorentini, Elisa, et al.
Publicado: (2022)

Safety and effectiveness of adalimumab in patients with rheumatoid arthritis over 5 years of therapy in a phase 3b and subsequent postmarketing observational study
por: Burmester, Gerd R, et al.
Publicado: (2014)

Evidence for the prevention of enthesitis in HLA-B27/hβ(2)m transgenic rats treated with a monoclonal antibody against TNF-α
por: Milia, Anna Franca, et al.
Publicado: (2011)

Combination of denosumab and biologic DMARDs in inflammatory muscle-skeletal diseases and connective tissue diseases
por: Bruni, Cosimo, et al.
Publicado: (2022)

Combination of denosumab and biologic DMARDs in inflammatory muscle-skeletal diseases and connective tissue diseases
por: Bruni, Cosimo, et al.
Publicado: (2022)

TNFα blockade prevents the development of inflammatory bowel disease in HLA-B27 transgenic rats
por: Milia, Anna Franca, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_c6ui0rq1snj56v66a5b9eqhtoe